Bryan Wahl

Companies

• Tarsus Pharmaceuticals, Inc.General counsel Jan 21, 2021 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TPTarsus Pharmaceuticals, Inc. TARS63,959 shares²$4.8M at $74.57Mar 19, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 19, 2026Sold 4,231 shares at $67.00 of Tarsus Pharmaceuticals, Inc.²
• Mar 18, 2026Sold 4,125 shares at $68.71 of Tarsus Pharmaceuticals, Inc.²
• Mar 17, 2026Sold 4,084 shares at $69.42 of Tarsus Pharmaceuticals, Inc.²
• Mar 15, 2026Exercised options 24,236 shares of Tarsus Pharmaceuticals, Inc.³
• Mar 20, 2025Sold 3,084 shares at $50.11 of Tarsus Pharmaceuticals, Inc.⁴
• Mar 19, 2025Sold 3,261 shares at $47.40 of Tarsus Pharmaceuticals, Inc.⁴
• Mar 18, 2025Sold 3,341 shares at $46.29 of Tarsus Pharmaceuticals, Inc.⁴
• Mar 15, 2025Exercised options 19,213 shares of Tarsus Pharmaceuticals, Inc.⁵
• Mar 18, 2024Sold 4,436 shares at $30.60 of Tarsus Pharmaceuticals, Inc.⁶
• Mar 15, 2024Exercised options 12,038 shares of Tarsus Pharmaceuticals, Inc.⁶
• Nov 30, 2023Sold 8,356 shares at $16.31 of Tarsus Pharmaceuticals, Inc.⁷
• Nov 29, 2023Exercised options 23,920 shares of Tarsus Pharmaceuticals, Inc.⁷
• Mar 23, 2023Sold 371 shares at $12.15 of Tarsus Pharmaceuticals, Inc.⁸
• Mar 22, 2023Sold 357 shares at $12.64 of Tarsus Pharmaceuticals, Inc.⁸
• Mar 21, 2023Sold 350 shares at $12.89 of Tarsus Pharmaceuticals, Inc.⁸
• Mar 20, 2023Sold 357 shares at $12.61 of Tarsus Pharmaceuticals, Inc.⁹
• Mar 17, 2023Sold 339 shares at $13.28 of Tarsus Pharmaceuticals, Inc.⁹
• Mar 16, 2023Sold 337 shares at $13.43 of Tarsus Pharmaceuticals, Inc.¹⁰
• Mar 15, 2023Exercised options 4,790 shares of Tarsus Pharmaceuticals, Inc.¹⁰
• Dec 2, 2022Sold 1,154 shares at $16.90 of Tarsus Pharmaceuticals, Inc.¹¹
• Dec 1, 2022Sold 1,164 shares at $16.75 of Tarsus Pharmaceuticals, Inc.¹²
• Nov 30, 2022Sold 1,183 shares at $16.50 of Tarsus Pharmaceuticals, Inc.¹²
• Nov 29, 2022Exercised options 10,251 shares of Tarsus Pharmaceuticals, Inc.¹²